Log In
Print
BCIQ
Print
Print this Print this
 

iOWH032

  Manage Alerts
Collapse Summary General Information
Company Program for Appropriate Technology in Health (PATH)
DescriptionOral small molecule inhibitor of the cystic fibrosis transmembrane conductance regulator (CFTR)
Molecular Target Cystic fibrosis transmembrane conductance regulator (CFTR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationDiarrhea (infectious)
Indication DetailsTreat acute secretory diarrhea
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today